Category: Biotech

Digital Therapeutics Deal Toy

Lucite deal toy, incorporating a spinning logo, celebrating growth capital provided to New York City-based Click Therapeutics. The debt financing will be used for the commercialization of several therapies, including one aimed at smoking cessation.

(21AKL594)
1 Image

Nasdaq IPO Deal Toy

Lucite deal toy celebrating the initial public offering (IPO) of Bluejay Diagnostics. The diagnostics and medical device firm is based in Acton, Massachusetts.

(21AKL655)
1 Image

Test Tube-Inspired Lucite Tombstone

Lucite tombstone commemorating a capital raise by Aditx Therapeutics (Aditxt). The life sciences and biotech firm is based in Richmond, Virginia.

(21AKL251)
1 Image

Gene-Themed Pharmaceutical Deal Tombstone

Lucite deal tombstone commemorating an agreement for global rights to gout treatment drug ARO-XDH. The agreement was reached between Dublin, Ireland-based Horizon Therapeutics and Arrowhead Pharmaceuticals, headquartered in Pasadena, California.

(21ALJ356)
2 Images
Custom Lucite celebrating a deal for global rights to the preclinical "gene-silencing" drug ARO-XDH.

Custom Lucite Embedment with Drug Vial

Lucite embedment with drug vial commemorating a study of a treatment for solid tumor cancer.

(21ADH006)
1 Image

DNA Strand-Inspired Licensing Commemorative

Lucite commemorative celebrating a development and commercialization agreement between Takeda and Arrowhead Pharmaceuticals.

(21ALJ357)
2 Images
Custom Lucite commemorating a development and commercialization agreement between Japanese drug maker Takeda and California-based Arrowhead Pharmaceuticals. The agreement centers on drugs that treat disease by using RNA to block gene expression.

Pill-Themed Bond Offering Tombstone

Financial tombstone marking the successful placement by Siegfried Holding of a senior bond. The Swiss firm provides development and production services to the pharmaceutical and life sciences sectors.

(21LSS233)
2 Images
Back view of crystal tombstone commemorating a senior bond offering by Siegfried Holding. Based in Switzerland, the life sciences company provides both primary and secondary drug manufacturing.